Literature DB >> 14238923

STUDIES ON ANTIBODY PRODUCTION. XI. VARIATION IN THE SECONDARY RESPONSE AS A FUNCTION OF THE LENGTH OF THE INTERVAL BETWEEN TWO ANTIGENIC STIMULI.

A I FECSIK, W T BUTLER, A H COONS.   

Abstract

As the interval between two antigenic stimuli to mice is lengthened, the magnitude of the response to the second dose increases up to approximately 40 days; thereafter it remains at a fairly constant, high level.

Entities:  

Keywords:  ANTIBODY FORMATION; DIPHTHERIA TOXOID; EXPERIMENTAL LAB STUDY; HEMAGGLUTINATION; IMMUNIZATION; MICE

Mesh：

Substances：

Year:  1964        PMID： 14238923      PMCID： PMC2137782          DOI： 10.1084/jem.120.6.1041

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  8 in total

1.  Differences in primary and secondary immunizability of inbred mice strains.

Authors:  J IPSEN
Journal:  J Immunol       Date:  1959-10       Impact factor: 5.422

2.  Effect of dosage and interval between injections on the antibody response to polyvalent influenza vaccine.

Authors:  W J MOGABGAB; B HOLMES; R J BRIGHTWELL; C W RESLER
Journal:  J Lab Clin Med       Date:  1961-09

3.  The significance of the inoculation interval in vaccination with polyvalent dysentery and combined typhoid-dysentery-tetanus vaccines.

Authors:  K RAUSS; I KETYI; L RETHY; I JOO
Journal:  Acta Microbiol Acad Sci Hung       Date:  1959

4.  Poliovirus antibody response after various vaccination schedules and at different ages.

Authors:  D R MACLEOD; C W ARMSTRONG; G W MOSS; F C POTTER; R J WILSON
Journal:  Can Med Assoc J       Date:  1959-09-15       Impact factor: 8.262

5.  Participation of the popliteal lymph node and spleen in the production of diphtheria antitoxin in the rabbit.

Authors:  A B STAVITSKY
Journal:  J Infect Dis       Date:  1954 May-Jun       Impact factor: 5.226

6.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

7.  Antibody Response and Systemic Reactions after Inoculation of a New Type of T.A.B.C. Vaccine.

Authors:  A Felix; S G Rainsford; E J Stokes
Journal:  Br Med J       Date:  1941-03-22

8.  Tetanus Prophylaxis and Circulating Antitoxin in Men and Women.

Authors:  D M Marvell; H J Parish
Journal:  Br Med J       Date:  1940-12-28
  8 in total
  21 in total

1.  The effect of antigen doses and time intervals between antigen injections on secondary, tertiary and quaternary antibody responses. Establishment of hyperimmunization with bovine serum albumin in mice treated with capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; F Ota; T Kobayashi; O Kato; N Kato
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

2.  Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice.

Authors:  G D Snell; M Cherry; I F McKenzie; D W Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

3.  Antibody production in mice. I. The analysis of immunological memory.

Authors:  T Hamaoka; M Kitagawa; Y Matsuoka; Y Yamamura
Journal:  Immunology       Date:  1969-07       Impact factor: 7.397

4.  Immunization of man with salmonella vaccine and tetanus-diphtheria vaccine. Dose-response relationship, secondary response, and competition of antigens.

Authors:  H A Clasener
Journal:  J Hyg (Lond)       Date:  1967-12

5.  Development of the secondary hemolysin response in hibernating ground squirrels (Citellus tridecemlineatus).

Authors:  B N Jaroslow
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

6.  Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses.

Authors:  Siegfried Hapfelmeier; Melissa A E Lawson; Emma Slack; Jorum K Kirundi; Maaike Stoel; Mathias Heikenwalder; Julia Cahenzli; Yuliya Velykoredko; Maria L Balmer; Kathrin Endt; Markus B Geuking; Roy Curtiss; Kathy D McCoy; Andrew J Macpherson
Journal:  Science       Date:  2010-06-25       Impact factor: 47.728

7.  HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network.

Authors:  G J Gorse; D H Schwartz; B S Graham; T J Matthews; D M Stablein; S E Frey; R B Belshe; M L Clements; P F Wright; M Eibl
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

8.  Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Authors:  Mark W Lamere; Amy Moquin; F Eun-Hyung Lee; Ravi S Misra; Patrick J Blair; Laura Haynes; Troy D Randall; Frances E Lund; Denise A Kaminski
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

9.  Persistence of immunological memory to soluble protein antigens.

Authors:  W O Weigle
Journal:  Immunology       Date:  1966-04       Impact factor: 7.397

10.  The serological assessment of a tetanus toxoid field trial.

Authors:  K W Newell; D R Leblanc; G Edsall; L Levine; H Christensen; M H Montouri; N Ramirez
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.